UPDATE 1-AstraZeneca flop a fresh blow to cancer immunotherapy combination

* AstraZeneca raises stake in Circassia to 19.9 pct (Adds market reaction, context on other companies)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.